Merit Medical Systems, Inc. (MMSI) Stock
Merit Medical Systems stock price chart
MMSI stock quote & key statistics
Merit Medical Systems annual financials
Income statement →| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2025 | $1.51B | $128.5M | $3.83 |
| FY2024 | $1.36B | $120.4M | $3.48 |
| FY2023 | $1.26B | $94.4M | $3.01 |
| FY2022 | $1.15B | $74.5M | $2.69 |
| FY2021 | $1.07B | $48.5M | $2.37 |
Fiscal year ending December 31. Source: company filings via EODHD.
About Merit Medical Systems, Inc.
Merit Medical Systems, Inc. specializes in the design, development, manufacturing, and global marketing of single-use medical products tailored for interventional, diagnostic, and therapeutic procedures across various medical specialties. Operating through two primary segments, Cardiovascular and Endoscopy, the company focuses on providing innovative solutions primarily in cardiology, radiology, oncology, critical care, and endoscopy.
Within its Cardiovascular segment, Merit Medical offers a comprehensive range of products for both peripheral and cardiac interventions. These include devices for accessing, diagnosing, and treating conditions affecting peripheral vessels and organs, as well as solutions for various cardiac procedures such as angiography, electrophysiology, and cardiac rhythm management. The company also specializes in fluid management, hemodynamic monitoring, hemostasis, and other critical interventions to address diverse cardiovascular conditions.
In addition to its cardiovascular offerings, Merit Medical provides a broad array of Endoscopy products. These encompass pulmonary products like laser-cut tracheobronchial stents and dilation balloons, as well as gastroenterology products and specialized kits and accessories for endoscopic and bronchoscopic procedures. The company's portfolio extends to custom procedural solutions, including critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs, enhancing procedural efficiency and patient care.
Headquartered in South Jordan, Utah, Merit Medical Systems, Inc. was established in 1987. The company distributes its products globally, serving hospitals, alternate site-based physicians, technicians, and nurses through a combination of direct sales, distribution partnerships, original equipment manufacturers, and custom procedure tray manufacturers. Merit Medical remains committed to advancing medical innovation and improving patient outcomes through its ongoing dedication to research, development, and quality healthcare solutions.
Merit Medical Systems stock FAQ
What is the Merit Medical Systems stock ticker symbol?
Merit Medical Systems, Inc. trades on the NASDAQ under the ticker symbol MMSI.
What sector and industry is Merit Medical Systems in?
Merit Medical Systems, Inc. is classified in the Healthcare sector, Medical Instruments & Supplies industry.
How many employees does Merit Medical Systems have?
Merit Medical Systems, Inc. has about 7,500 full-time employees.
What were Merit Medical Systems's revenue and earnings last fiscal year?
Merit Medical Systems reported revenue of $1.51B and net income of $128.5M in fiscal 2025, with earnings per share of $3.83. Revenue grew 11.7% from the prior year.
Is Merit Medical Systems in the S&P SmallCap 600?
Yes. Merit Medical Systems, Inc. (MMSI) is a component of the S&P SmallCap 600, the benchmark index of profitable U.S. small-cap stocks.
Is Merit Medical Systems in the Russell 2000?
Yes. Merit Medical Systems, Inc. (MMSI) is a component of the Russell 2000, the benchmark index of U.S. small-cap stocks.
When did Merit Medical Systems go public?
Merit Medical Systems stock began trading on August 9, 1990.
S&P SmallCap 600 Healthcare stocks
All S&P SmallCap 600 →- ALKSAlkermes
- AMRXAmneal Pharmaceuticals
- ARQTArcutis Biotherapeutics
- ATRCAtriCure
- AZTAAzenta
- CONConcentra Group Holdings Parent
- GKOSGlaukos
- ICUIICU Medical
- INDVIndivior
- ITGRInteger
- LFSTLifeStance Health
- LGNDLigand Pharmaceuticals
- LMATLeMaitre Vascular
- NHCNational HealthCare
- OGNOrganon
- PTCTPTC Therapeutics
- PTGXProtagonist Therapeutics
- RDNTRadNet
- STAASTAAR Surgical
- TFXTeleflex
- TGTXTG Therapeutics
- VCYTVeracyte
- WAYWaystar
- WRBYWarby Parker